Magazine article Information Today

New Corporate Market Products and Organization at ISI

Magazine article Information Today

New Corporate Market Products and Organization at ISI

Article excerpt

Barbara Quint, co-editor with Paula J. Hane for NewsBreaks, is editor in chief of Information Today, Inc.'s Searcher: The Magazine for Database Professionals, columnist for Information Today, and a longtime online searcher. Her e-mail address is

Moving beyond its traditional academic and research institutional markets, the Institute for Scientific Information (ISI) ( announced at the end of August the creation of a new division and the launch of a new style of products for the corporate market. Designed for the pharmaceutical, biotechnology, and health-care market sectors, the new products will provide customized information and answers specifically for clinical and product development, market research, medical and regulatory affairs, and competitive intelligence professionals.

ISI based its decision to move toward "solution-based products and filtering tools" on market research into these high-revenue sectors. According to Mike Tansey, president and CEO of ISI, "Based on our internal R&D efforts we believe that ISI can extend the reach of its services by providing answers, not just data, for every step of the development and product launch process for organizations in these "

To implement the coming portfolio of customized products, ISI has created an international corporate business development department under Bill Gole, senior vice president, market development, and Alan Hess, vice president, corporate market development. Hess has a long history as an executive in medical and pharmaceutical areas. Most recently he was vice president of health-care products at Micromedex, another Thomson Company subsidiary.

The new products will seek to provide basic data support to companies. According to Gole, "The suite of products we are designing will answer basic informational questions quickly and efficiently at the desktop. We will provide instantaneously accessible answers designed to enhance productivity and shorten the drug development cycle."

The first release from the new department is a product line called MetaMaps, a series of evaluated clinical data sets designed to serve as decision-shaping tools for the pharmaceutical and biotechnology industries. (See the news release in the CD/DVD Today section on page 47.) Developed in partnership with MetaWorks (, MetaMaps consist of relational databases of extracted clinical data arranged in hierarchical tables based on the systematic review of key clinical trial literature relating to a particular disease setting or therapeutic area. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed


An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.